Multiple endocrine neoplasia type 1: Clinical aspects and implications for the management of duodenopancreatic endocrine tumors;Neoplasie endocrine multiple de type 1: Aspects cliniques, implications pour la prise en charge des tumeurs endocrines duodeno-pancreatiques

Hepato-Gastro

Volumn 7, Issue 5, 2000, Pages 365-372

  Cadiot, G ^a   Mignon, M ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A;

CLINICAL FEATURE; DUODENUM TUMOR; ENDOSCOPY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; PREVALENCE; PROGNOSIS; RISK FACTOR; SHORT SURVEY; TREATMENT INDICATION; ZOLLINGER ELLISON SYNDROME;

EID: 0033786507     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (49)

1. Familial multiple endocrine adenoma-peptic ulcer complex
2. Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds
3. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1
4. Multiple endocrine neoplasia type 1: Clinical and genetic topics
5. Evaluation prospective de la prevalence des tumeurs endocrines duodeno-pancreatiques non fonctionnelles dans la neoplasie endocrine multiple de type 1
6. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN1
7. Diagnostic des tumeurs neuroendocrines digestives
8. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia
9. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study
10. Histopathology and immunopathology of pancreatic endocrine tumors
11. Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia type 1
12. Surgery to cure the Zollinger-Ellison syndrome
13. Lethality of multiple endocrine neoplasia type 1
14. Cause of death in multiple endocrine neaplasia type 1
15. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1
16. Interest of the oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome
17. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia type 1
18. Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome
19. Glucagonomas: Clinical presentation, diagnosis, and advances in management
20. Calcitonin-secreting tumors of the pancreas: About six cases
21. Plasma chromagranin A in patients with multiple endocrine neoplasia type 1
22. New Immunoradiossay for plasma chromogranin A in endocrine tumors
23. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas
24. Imagerie des tumeurs endocrines de la region duodeno-pancreatique
25. Is endoscopic ultrasonography accurate for the localization of pancreatic and duodenal tumors in patients with multiple endocrine neoplasia type 1 ?
26. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome
27. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy
28. Usefulness of somatostatin receptor scintigraphy in the management of patients with the Zollinger-Ellison syndrome
29. Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1
30. Somatastatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas
31. Pancreatic islet cell tumor metostasis in multiple endocrine neoplasia type 1: Correlation with primary tumor size
32. Enteropancreatic maligancy associated with multiple endocrine neoplasia type 1
33. Multiple endocrine neoplasm, type 1: Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases
34. The glucagonoma syndrome: Clinical and pathologic features in 21 patients
35. Prognostic factors in patients with endocrine tumours of the duodeno-pancreatic area
36. The management of islet cell tumors in patients with multiple endocrine neoplasia type 1 (MEN1)
37. Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1
38. Current perspectives in the surgery of multiple endocrine neoplasias
39. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease: Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both
40. Clinical course of nonsurgically treated Zollinger-Ellison syndrome
41. Treatment of gastrinomas with pancreatoduodenectomy
42. Insulinomas associated with multiple endocrine neoplasia type 1: The need for a different surgical approach
43. Surgical aspects of hyperinsulinemic hypoglycemia
44. Intraoperative insulin measurement during surgical management of insulinomas
45. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma
46. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term antisecretory treatment
47. Oesophagite stenosante au cours du syndrome de Zollinger-Ellison
48. Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery
49. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison and multiple endocrine neoplasia type 1 : A prospective study